# Nuclide record erik-mittra (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/erik-mittra/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "erik-mittra" ;
  schema:name "Erik S. Mittra"@en ;
  schema:description "A Stanford-trained nuclear medicine doctor who leads the theranostics programme at Oregon Health & Science University and treats neuroendocrine tumour patients with radioactive peptide therapy."@en ;
  schema:url <https://nuclide.cc/people/erik-mittra/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.ohsu.edu/providers/erik-s-mittra-md-phd>, <https://netrf.org/specialist/erik-mittra-md-phd/> ;
  nuclide:tag "neuroendocrine", "PRRT", "clinician" ;
  schema:jobTitle "Professor of Diagnostic Radiology; Chief, Nuclear Medicine and Molecular Imaging; Director, Radiopharmaceutical Therapeutics, Oregon Health & Science University" ;
  nuclide:related <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/trials/netter-1/>, <https://nuclide.cc/technologies/radioembolisation-tare/>, <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/y-90/> .